Cellectis

Cellectis OCF/Debt

The Operating Cash Flow to Debt Ratio of Cellectis (CLLS) as of Oct 17, 2026 is -57.85 %. In the previous year, Operating Cash Flow to Debt Ratio was 38.63 % — a change of -249.76% (lower).

OCF/Debt

-57.85 %

YoY

-249.76%

Last updated:

Operating Cash Flow to Debt Ratio of Cellectis is 2025 -57.85 % . Operating Cash Flow to Debt Ratio of Cellectis was 2024 38.63 % . It decreases by -249.76% lower compared to the previous year.

The Cellectis OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
-5,043.45 USD
Jan 1, 2019
-145.23 USD
Jan 1, 2020
-225.88 USD
Jan 1, 2021
-356.32 USD
Jan 1, 2022
-262.00 USD
Jan 1, 2023
-58.77 USD
Jan 1, 2024
38.63 USD
Jan 1, 2025
-57.85 USD
The Cellectis OCF/Debt history
YEAROCF/DebtYoY
-57.85 %-249.76%
38.63 %-165.73%
-58.77 %-77.57%
-262.00 %-26.47%
-356.32 %+57.74%
-225.88 %+55.53%
-145.23 %-97.12%
-5,043.45 %-96.72%
-153,902.94 %+8,592.61%
-1,770.50 %-1,187.81%
162.76 %-85.68%
1,136.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cellectis Stock analysis

What does Cellectis do? Cellectis SA, headquartered in Paris, France, is a clinical-stage biotechnology company specializing in gene-editing technologies. It develops allogeneic CAR-T cell therapies for immuno-oncology, including product candidates like BALLI-01 for relapsed/refractory acute lymphoblastic leukemia and NatHaLi-01 for B-cell non-Hodgkin's lymphoma. The company also focuses on gene therapy for other therapeutic areas, with additional candidates targeting large B-cell lymphoma and renal cell carcinoma. Founded in 1999, it has 222 employees and has been listed on the stock market since 2007. Cellectis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellectis stock

Operating Cash Flow to Debt Ratio of Cellectis is -57.85 % in 2025.

Operating Cash Flow to Debt Ratio of Cellectis changed from 38.63 % to -57.85 %, representing a -249.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Cellectis since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Cellectis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cellectis

All Key Metrics — Cellectis